Pavan Lall And Sohini Das

Stories by Pavan Lall And Sohini Das

Zerodha's Nikhil Kamath is India's youngest new billionaire

Zerodha's Nikhil Kamath is India's youngest new billionaire

Rediff.com   9 Mar 2021

Last year, Nikhil Kamath and his brother Nithin jettisoned into a club of the country's 100 wealthiest with their net worth pegged at around Rs 24,000 crore

Are you ready for the Citroen?

Are you ready for the Citroen?

Rediff.com   8 Mar 2021

Making a debut in India with an SUV, Citroen's products in the next couple of years will clearly chart and define its destiny in what has become both a vibrant but also a daunting market for foreign entrants, says Pavan Lall.

Will the new A4 put Audi back in the race?

Will the new A4 put Audi back in the race?

Rediff.com   2 Mar 2021

The answer would have been an unequivocal yes had the A4 been priced more aggressively, says Pavan Lall.

A masterstroke that keeps demand for Rolex watches sky-high

A masterstroke that keeps demand for Rolex watches sky-high

Rediff.com   28 Feb 2021

Rolex has been masterful at playing the demand-supply game, limiting its issue of coveted and in-demand watches to only one or two pieces per dealership.

Public may get COVID-19 vaccine by April

Public may get COVID-19 vaccine by April

Rediff.com   22 Feb 2021

Anybody over 50 years of age or with co-morbidities can get a date, place and time of choice for getting the vaccine shots.

Low turnout forces govt to mull private rollout of Covid vaccine

Low turnout forces govt to mull private rollout of Covid vaccine

Rediff.com   10 Feb 2021

Two weeks after the vaccination programme started, about 37 per cent of the targeted 10 million healthcare professionals had received the first shot. This slow rate may prompt the government to allow vaccines in the private market sooner, to use up the doses before they expire, Sohini Das reports.

Lupin aims to enter Chinese market in the next one year

Lupin aims to enter Chinese market in the next one year

Rediff.com   8 Feb 2021

Once a difficult market to crack, in recent years, China has relatively opened up its drug market, enacting reforms and speeding up approval time.

More Covid vaccine candidates get approval for clinical trials in India

More Covid vaccine candidates get approval for clinical trials in India

Rediff.com   6 Feb 2021

Ahmedabad-based Zydus Cadila, Bharat Biotech's intra-nasal candidate are among the candidates who got approval from the expert panel to conduct clinical trials, Sohini Das reports.

More Indians will take vaccine if politicians do: Survey

More Indians will take vaccine if politicians do: Survey

Rediff.com   5 Feb 2021

In India, Opposition parties along with healthcare professionals have urged the government, including Prime Minister Narendra Modi and top leaders, to take either of the Covishield or Covaxin doses, which could help in drastically reducing trust and fear issues amongst citizens., reports Sohini Das.

The A is now The Quorum: Rana Kapoor family-led business club changes hands

The A is now The Quorum: Rana Kapoor family-led business club changes hands

Rediff.com   25 Jan 2021

The Quorum in Mumbai aims to introduce and extend its blend of hospitality and philosophy of being community-led, content-driven, design-focused and experiential.

Why early applicant Pfizer's Covid vaccine is delayed

Why early applicant Pfizer's Covid vaccine is delayed

Rediff.com   19 Jan 2021

Pfizer sought to participate in the Subject Expert Committee consultations towards an emergency use authorisation for its Covid-19 vaccine. However, the company representatives have been unable to participate in the meetings because of extremely short notices of a few hours or less and time-zone limitations.

Volvo S60 takes the safety-first mantra seriously

Volvo S60 takes the safety-first mantra seriously

Rediff.com   19 Jan 2021

With all the safety equipment that it features, the S60 could be the smarter, more mature sedan alternative that consumers in this price category want, says Pavan Lall.

Serum Institute may supply 400 million doses to Gavi-Covax

Serum Institute may supply 400 million doses to Gavi-Covax

Rediff.com   19 Jan 2021

Serum Institute already has two deals of 100 million each to supply the Oxford-AstraZeneca and the Novavax vaccine to Gavi-Covax at $3 per dose.

V G Somani: The head of DCGI known as man of actions, not of words

V G Somani: The head of DCGI known as man of actions, not of words

Rediff.com   18 Jan 2021

'Safety is my first priority.' 'I need to ensure that any drug or vaccine that our citizens get is first safe.'

Serum Institute began its journey in a small lab in stud farm

Serum Institute began its journey in a small lab in stud farm

Rediff.com   16 Jan 2021

The Covishield maker's forte throughout the past half a century has been a combination of affordable vaccines and high volumes. Its tetanus, diphtheria and measles vaccines are known throughout the world, reports Sohini Das.

'It'll take 3-4 years to vaccinate 80% of population'

'It'll take 3-4 years to vaccinate 80% of population'

Rediff.com   11 Jan 2021

'We are hoping by March, the government allows us to export and give it to the private market.'

COVID-19 Vaccine: Vial, syringe makers ramp up

COVID-19 Vaccine: Vial, syringe makers ramp up

Rediff.com   2 Jan 2021

'The government should put the whole road map together for the vaccine and decide how industry can support...' 'They should allow the private sector to vaccinate.'

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

Rediff.com   31 Dec 2020

The expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine.

Want to drive a BMW? Check out 2 Series

Want to drive a BMW? Check out 2 Series

Rediff.com   29 Dec 2020

For those who've always wanted to drive a BMW in India, the 2 Series is easily the most fun to drive everyday car that money can buy.

Kids will have to wait for a COVID-19 vaccine

Kids will have to wait for a COVID-19 vaccine

Rediff.com   28 Dec 2020

The primary objective was to get the adult vaccine as children rarely have a severe form of the disease. Once schools reopen, the demand for vaccines for children under 12 may soar.